VB vs XBI

Vanguard Small-Cap ETF vs SPDR S&P Biotech ETF

Quick take
  • • VB has the lower expense ratio at 0.03% vs 0.35% for XBI.
  • • VB pays a higher dividend yield (1.26%).

Side-by-side metrics

MetricVBXBI
Expense ratio
Annual fee. Lower is better.
0.03%0.35%
Dividend yield
Trailing 12-month yield.
1.26%0.35%
AUM
Assets under management — bigger funds are typically more liquid.
$178.19B$10.92B
YTD return
15.28%28.80%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
1.091.01
P/E ratio
19.78—
Last price
$295.88$156.41
Inception
——
Issuer
VanguardState Street

VB top holdings

Top holdings · VB
NTRANatera Inc0.72%
TWLOTwilio Inc Class A0.57%
RVMDRevolution Medicines Inc Ordinary Shares0.53%
ILMNIllumina Inc0.52%
PEverpure Inc Class A0.52%
OKTAOkta Inc Class A0.44%
MRNAModerna Inc0.44%
EMEEMCOR Group Inc0.42%
CRDOCredo Technology Group Holding Ltd0.42%
JBLJabil Inc0.38%
Sector breakdown · VB
Real Estate7.6%
Consumer Cyclical11.4%
Basic Materials4.4%
Consumer Defensive3.4%
Technology18.5%
Communication Services2.9%
Financial Services12.4%
Utilities3.2%
Industrials17.5%
Energy4.3%
Healthcare14.3%

XBI top holdings

Top holdings · XBI
MRNAModerna Inc2.37%
NTRANatera Inc1.82%
HALOHalozyme Therapeutics Inc1.77%
TWSTTwist Bioscience Corp1.77%
BIIBBiogen Inc1.75%
AMGNAmgen Inc1.73%
EXELExelixis Inc1.73%
UTHRUnited Therapeutics Corp1.72%
ABBVAbbVie Inc1.71%
GILDGilead Sciences Inc1.70%
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%

About VB

VB (Vanguard Small-Cap ETF) is US small-cap stocks across sectors. Managed by Vanguard, the fund carries $178.2B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.26%. Its largest holding is Natera Inc (NTRA), which represents 0.7% of the portfolio. Real Estate is the fund's largest sector exposure at 7.6%.

About XBI

XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.